Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03481647 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of an Oral Care Programme for Head and Neck Cancer Patients

StatusRecruiting
PhaseNot applicable
Started2018-01-08
View on ClinicalTrials.gov ↗

Amendment history

2025-04-16
Study Status, Sponsor/Collaborators, Eligibility v4
Primary completion date2022-12-31→2026-12-31
Completion date2023-12-31→2026-12-31
Eligibility criteria-98 characters
Inclusion Criteria: Patients with ≥ 16 own teeth and no removable dentures, Patients scheduled to receive full dose of curative RT including the major salivary glands in the radiation field Exclusion Criteria: Patients who get surgery to remove their tumor Patients with recurrent cancer Patients with severe cognitive impairment.
Collaborators5 to 8 entries
The Sjöberg Foundation TUA research funding: The Sahlgrenska Academy/Region Västra Götaland Malmö University
2021-08-25
Study Status v3
Primary completion date2020-12-31→2022-12-31
2019-09-17
Study Status, Sponsor/Collaborators v2
Collaborators3 to 5 entries
Kalmar County Hospital Norrlands University Hospital
2019-04-23
Study Status v1
Re-verified, no change to tracked fields
2018-03-27
Original filing
This study will evaluate the effect of an intensified oral care programme on prevalence, severity and duration of mucositis in patients undergoing treatment for cancer in the head and neck region. Patients in the control group get professional oral care once a week.
Trial Details
NCT Number NCT03481647
Lead Sponsor Göteborg University
Collaborators: Ryhov County Hospital, Region Jönköping County, Swedish Cancer Foundation, Kalmar County Hospital, Norrlands University Hospital, The Sjöberg Foundation, TUA research funding: The Sahlgrenska Academy/Region Västra Götaland, Malmö University
Conditions Head and Neck Cancer
Enrollment 150 participants
Start Date 2018-01-08
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-20